Ms. Lauren Fischer is the Vice President of Corporate Affairs for Eli Lilly Canada Inc. In this role she is responsible for all aspects of corporate affairs including federal and provincial government affairs, policy development, provincial and private reimbursement, pricing, health economics, advocacy relations, communications, strategic partnerships and public affairs. Ms. Fischer is also a member of the Senior Management Team of Eli Lilly Canada.
Since joining Eli Lilly Canada in 2001, Ms. Fischer has held a number of positions within the marketing and corporate affairs divisions including Cymbalta Marketing Manager, Senior Manager of Government and Economic Affairs, Manager of Government and Stakeholder Relations for Ontario and Market Access Associate.
Prior to joining Lilly, Ms. Fischer held a number of positions for the Department of Foreign Affairs and International Trade in Buenos Aires, Washington and Ottawa.
Ms. Fischer obtained a Master of Business Administration in 2001 from INSEAD and a Bachelor of Arts Degree in Political Science from McGill University in 1993.
Day 1: Oct 6, 2020
Strategies for Managing Through the Adjusted Timeline and Transition to Implementation of the New Pricing Guidelines
Given the uncertainties created by the change in implementation date to the new pricing guidelines, navigating the marketplace will be challenging. Fine-tune your pricing strategy as the new guidelines gain clarity. Take away a road map to help your organization with:
- Strategies for product positioning and pricing
- Insights about determining factors on whether medicines will be classified as Category I or Category II
- Understanding what impact the current consultation process could have on the final guidelines and on your organization
Gain clarity on how to align your pricing strategies with the new PMPRB pricing guidelines as they emerge under the new implementation timeline
Day 2: Oct 7, 2020
Day 3: Oct 8, 2020